FdaApplication
NDA 208026
Identifiers
- fda_app_no: NDA208026
Properties
| Property | Value |
|---|---|
| applicant_name | BOEHRINGER INGELHEIM PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2016-05-27 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| JENTADUETO XR | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | 2.5MG;1GM | TABLET, EXTENDED RELEASE;ORAL |
| JENTADUETO XR | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | 5MG;1GM | TABLET, EXTENDED RELEASE;ORAL |
2 products